NACL Industries Limited (NACLIND) Fair Value & Analysis
Basic Materials · IN · Market cap ₹51.0B
Fair value as of: Aug 13, 2026
From 15 valuation models · updated 4 days ago
Fair value updated Aug 13, 2026, revised from ₹316.25 to ₹316.60 (+0.1%) since Aug 8, 2026. Share price −18.7% over the past month.
Below-average quality, screening 83% undervalued on our models.
What matters now
- The price is below even our cautious bear case (₹237.45). The market is more pessimistic than our downside scenario.
- Solid quality (47/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range ₹36.84 – ₹323.30 · fair‑value band ₹237.45 – ₹395.74 · the ₹173.45 price screens below the ₹316.60 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
NACL Industries Limited (NACLIND) currently trades at ₹173.45, while our model-based Fair Value estimate is ₹316.60, implying the stock looks roughly 82.5% undervalued today. The Quality Score stands at 47/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, NACL Industries Limited generated revenue of ₹15.8B at a net margin of 0.3%. Revenue grew 79.2% year over year. It earns a return on equity of 0.8%. Net debt stands at ₹2.8B. Fundamentals as of Aug 13, 2026
Our scenario range runs from ₹237.45 (bear case) to ₹395.74 (bull case); at ₹173.45, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 49% below its 52-week high and 54% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -17% fair-value upside, at 83%, NACLIND screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 15 models by family
Widest divergence: Asset-Based (₹1,862) versus Earnings-Based (₹188.82). Highest evidence: Residual Income (76).
Notify me when NACLIND reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 46 · Market factors (momentum, volatility) 40
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
NACL Industries Limited manufactures and sells agrochemicals in India. The company offers a range of technical products, including myclobutanil, propiconazole, profenofos, tricyclazole, pretilachlors, thiamethoxam, lambda cyhalothrin, bifenthrin, azoxystrobin, tebuconazole, difenoconazole, thifluzamide, bispyribac sodium, clodinafop propargyl, metribuzin, …
Full company description
NACL Industries Limited manufactures and sells agrochemicals in India. The company offers a range of technical products, including myclobutanil, propiconazole, profenofos, tricyclazole, pretilachlors, thiamethoxam, lambda cyhalothrin, bifenthrin, azoxystrobin, tebuconazole, difenoconazole, thifluzamide, bispyribac sodium, clodinafop propargyl, metribuzin, quizalofop ethyl, haloxyfop r methyl, and glufosinate ammonium; and formulations, such as insecticides, fungicides, herbicides, and plant growth regulators and nematicides, as well as pesticides and acaricides. It also provides toll manufacturing services for various multinational companies. The company also exports its products. It markets and sells its products through a network of retail dealers. The company was formerly known as Nagarjuna Agrichem Limited and changed its name to NACL Industries Limited in September 2017. The company was incorporated in 1986 and is based in Hyderabad, India. NACL Industries Limited is a subsidiary of Coromandel International Limited.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
NACL Industries Limited reported revenue of ₹15.8B in FY2026 versus ₹16.4B in FY2022, a compound −0.9%/yr. Reported net income was ₹45.7M in FY2026, compounding −50.1%/yr from FY2022.
Watch NACLIND: get an alert when its fair value changes →
Peer Group
Agricultural Inputs · 177 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Agricultural Inputs median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Corteva, Inc CTVA | $76.22 | $27.81 | -64% |
| Nutrien Ltd NTR | C$93.60 | C$81.69 | -13% |
| Qinghai Salt Lake Industry Co 000792 | ¥27.65 | ¥21.26 | -23% |
| CF Industries Holdings CF | $120.01 | $161.00 | +34% |
| SABIC Agri-Nutrients Company 2020 | 122.90 SAR | 127.31 SAR | +4% |
| Yara International ASA YAR | kr 418.10 | kr 67.25 | -84% |
| Yunnan Yuntianhua Co 600096 | ¥29.82 | ¥42.12 | +41% |
| Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 | ¥45.86 | ¥38.01 | -17% |
| Coromandel International Limited COROMANDEL | ₹2,089 | ₹1,129 | -46% |
| UPL Limited UPL | ₹570.50 | ₹387.06 | -32% |
Compare NACL Industries Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is NACL Industries Limited (NACLIND) overvalued or undervalued?
What is the fair value of NACLIND?
What is the quality score of NACLIND?
What is the revenue of NACL Industries Limited (NACLIND)?
What is the net profit margin of NACLIND?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track NACL Industries Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.